23andMe Holding Co. (ME)

USD 3.14

(-3.09%)

Operating Expenses Summary of 23andMe Holding Co.

  • 23andMe Holding Co.'s latest annual operating expenses in 2023 was 420.73 Million USD , down -8.24% from previous year.
  • 23andMe Holding Co.'s latest quarterly operating expenses in 2024 Q1 was 86.68 Million USD , up 0.85% from previous quarter.
  • 23andMe Holding Co. reported a annual operating expenses of 458.5 Million USD in annual operating expenses 2022, up 18.45% from previous year.
  • 23andMe Holding Co. reported a annual operating expenses of 387.09 Million USD in annual operating expenses 2021, up 28.09% from previous year.
  • 23andMe Holding Co. reported a quarterly operating expenses of 85.95 Million USD for 2023 Q4, down -14.77% from previous quarter.
  • 23andMe Holding Co. reported a quarterly operating expenses of 98.2 Million USD for 2023 Q2, down -27.64% from previous quarter.

Annual Operating Expenses Chart of 23andMe Holding Co. (2023 - 2018)

Historical Annual Operating Expenses of 23andMe Holding Co. (2023 - 2018)

Year Operating Expenses Operating Expenses Growth
2023 420.73 Million USD -8.24%
2022 458.5 Million USD 18.45%
2021 387.09 Million USD 28.09%
2020 302.2 Million USD -13.95%
2019 351.18 Million USD -5.54%
2018 371.77 Million USD 0.0%

Peer Operating Expenses Comparison of 23andMe Holding Co.

Name Operating Expenses Operating Expenses Difference
Bionano Genomics, Inc. 148.99 Million USD -182.384%
Prenetics Global Limited 60.73 Million USD -592.717%
Star Equity Holdings, Inc. 16.27 Million USD -2485.626%
CareDx, Inc 277.76 Million USD -51.469%
Exact Sciences Corporation 2.06 Billion USD 79.581%
Exagen Inc. 52.29 Million USD -704.568%
Inotiv, Inc. 246.9 Million USD -70.404%
Guardant Health, Inc. 901.62 Million USD 53.336%
Biodesix, Inc. 77.41 Million USD -443.449%
BioNexus Gene Lab Corp. 3.92 Million USD -10624.542%
Precipio, Inc. 13.63 Million USD -2985.005%
iSpecimen Inc. 16.27 Million USD -2484.789%
Natera, Inc. 938.98 Million USD 55.193%
Aspira Women's Health Inc. 24.11 Million USD -1644.767%
Standard BioTools Inc. 113.48 Million USD -270.726%
Castle Biosciences, Inc. 242.78 Million USD -73.296%
Personalis, Inc. 128.14 Million USD -228.328%
Aclaris Therapeutics, Inc. 110.52 Million USD -280.668%
Applied DNA Sciences, Inc. 16.48 Million USD -2451.951%
OpGen, Inc. 30.65 Million USD -1272.345%
T2 Biosystems, Inc. 41.49 Million USD -913.961%
Myriad Genetics, Inc. 600.1 Million USD 29.89%
ICON Public Limited Company 755.64 Million USD 44.321%
NeoGenomics, Inc. 341.25 Million USD -23.291%
Star Equity Holdings, Inc. 16.27 Million USD -2485.626%
IDEXX Laboratories, Inc. 1.09 Billion USD 61.501%
RadNet, Inc. 268.87 Million USD -56.477%
MDxHealth SA 71.25 Million USD -490.453%
Psychemedics Corporation 11.33 Million USD -3612.132%
Illumina, Inc. 3.81 Billion USD 88.966%
Check-Cap Ltd. 19.28 Million USD -2081.433%
Twist Bioscience Corporation 354.18 Million USD -18.791%
DarioHealth Corp. 62.17 Million USD -576.713%
Fulgent Genetics, Inc. 171.9 Million USD -144.746%
Sera Prognostics, Inc. 39.91 Million USD -954.02%
ENDRA Life Sciences Inc. 10.52 Million USD -3899.084%
OPKO Health, Inc. 574.68 Million USD 26.789%
Medpace Holdings, Inc. 187.68 Million USD -124.176%
Neogen Corporation 405.23 Million USD -3.824%
Intelligent Bio Solutions Inc. 11.7 Million USD -3493.306%
Prenetics Global Limited 60.73 Million USD -592.717%
Mainz Biomed B.V. 27.15 Million USD -1449.413%
bioAffinity Technologies, Inc. 8.76 Million USD -4700.234%
Trinity Biotech plc 46.49 Million USD -804.899%
Neuronetics, Inc. 82.25 Million USD -411.474%
Sotera Health Company 300.46 Million USD -40.027%
bioAffinity Technologies, Inc. 8.76 Million USD -4700.234%